Skip to main content
OpenTrials
Completed

NCT Number: NCT05349708

Telehealth Home-monitoring for Frailty in Cardiac Surgery

Cardiac surgical interventions are increasingly offered to vulnerable patients or patients living with frailty. Unfortunately, frailty has been shown to be an independent predictor of poorer outcome and increased health care resources in terms of readmission to hospital or visit to the ER after discharge. We hypothesize that the use of a comprehensive Telehealth home-monitoring program could reduce emergency room visits and re-hospitalization after heart surgery.

Frailty in all patients will be determined using the Edmonton frailty scale (EFS) as is part of the current standard of care for all patients at the NBHC since 2018. We plan to implement the Telehealth intervention on all 120 consecutively enrolled patients identified as vulnerable and/or frail and discharged from hospital within 10 days of their surgery. The primary outcome of interest will be rates of ER visit and readmission to hospital within 30 days of discharge compared to propensity score matched historical control patients. A power calculation suggests that 120 patients per group are necessary explaining why the intervention group will be 120 patients. We chose to compare our intervention to a matched group of 240 individuals from historical data which already captures follows patients 30 days after surgery but is limited in its Telehealth intervention. Duration of the study is 12 months.

Completed

Looking for future studies?

Notify Me

Key information

Age range

60 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

New Brunswick Heart Centre, Saint John Regional Hospital

Saint John, New Brunswick, E2L4L4, Canada

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients, aged 55 years or older, undergoing elective isolated coronary artery bypass grafting (CABG), aortic valve repair/replacement, mitral valve repair/replacement or combined CABG/valve procedures.
  • Patients defined as pre- vulnerable, vulnerable or frail based on the Edmonton frailty scale (> 4 considered pre- vulnerable) as defined prior to surgery

Exclusion criteria

  • Medical reasons for exclusion
  • Patients who have unstable or recent unstable cardiac syndrome requiring urgent (within 24hr) or emergent surgery
  • Acute endocarditis who are at higher risk for adverse events
  • Dialysis dependent who are at higher risk for adverse events
  • Patients who have cognitive deficits, visual impairments, inability to read or major difficulties with electronic devices that would preclude use of the intervention
  • Patients who do not have any support or potential caregivers to help facilitate their transition home
  • Patients undergoing minimally invasive surgery which has been shown to enhance recovery
  • Patients unable to be discharged home within 10 days of their surgery. The average length of hospitalization is 5 days with frail patients often requiring additional time but usually within 10 days unless some major barrier exists in allowing discharge home.
  • Patients who are transferred to another hospital for recovery or care.

Treatment and study plan

THE-FACS

Device

Telehealth home-monitoring tablet and blood pressure cuff

Primary outcomes

  1. Rates of emergency room visit and readmission to hospital

    Time frame: 30 days of discharge post-cardiac surgery

    The aim was to compare the rate of emergency room visits and readmission to hospital within 30 days of discharge between two groups of patients: frail, post-surgery cardiac surgery patients who went home with the intervention for self-monitoring of health versus historical controls

Secondary outcomes

  1. Length of hospital stay (LOS, days) and discharge disposition

    Time frame: Duration of stay at the hospital post-cardiac surgery

    The post-surgery inclusion criterion was the LOS of 10 days or less and home-discharge. The investigators, therefore, assessed the LOS and discharge disposition of the frail participants who consented to participate in the study to understand the challenges in recovery and ability to participate in the study.

  2. Rate of readmission to hospital and/or ER visit and reasons

    Time frame: 30 days of discharge post-cardiac surgery

    The aim of the telehealth home monitoring platform was to reduce hospital readmission and/ or ER visits within 30 days of discharge post-cardiac surgery. The investigators, therefore, wanted to explore the rates and causes for the above-mentioned outcomes.

  3. Percentage of patients who faced difficulties with the Telehealth intervention and causes of the same

    Time frame: 30 days of discharge post-cardiac surgery

    Identification of the major challenges frail participants faced in using a technology-based home monitoring program to self-monitor their health and recovery post-cardiac surgery. A participation-satisfaction questionnaire was used to assess the percentage of patients who could/ count not use the intervention and the reasons for such (technological challenges, connectivity ussies, etc.).

Sponsors and collaborators

Lead sponsor

New Brunswick Heart Centre

Other

Registry information

Official study title

Benefit of a Telehealth Home-monitoring Program for Vulnerable Patients and Patients Living With Frailty Undergoing Heart Surgery

Acronym: THE-FACS

Important dates

Study start
2019
Primary completion
2020
Study completion
2021
First posted
Apr 27, 2022
Registry last updated
Apr 27, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.